• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓性肌萎缩症护理标准共识声明。

Consensus statement for standard of care in spinal muscular atrophy.

作者信息

Wang Ching H, Finkel Richard S, Bertini Enrico S, Schroth Mary, Simonds Anita, Wong Brenda, Aloysius Annie, Morrison Leslie, Main Marion, Crawford Thomas O, Trela Anthony

机构信息

Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, California 94305-5235, USA.

出版信息

J Child Neurol. 2007 Aug;22(8):1027-49. doi: 10.1177/0883073807305788.

DOI:10.1177/0883073807305788
PMID:17761659
Abstract

Spinal muscular atrophy is a neurodegenerative disease that requires multidisciplinary medical care. Recent progress in the understanding of molecular pathogenesis of spinal muscular atrophy and advances in medical technology have not been matched by similar developments in the care for spinal muscular atrophy patients. Variations in medical practice coupled with differences in family resources and values have resulted in variable clinical outcomes that are likely to compromise valid measure of treatment effects during clinical trials. The International Standard of Care Committee for Spinal Muscular Atrophy was formed in 2005, with a goal of establishing practice guidelines for clinical care of these patients. The 12 core committee members worked with more than 60 spinal muscular atrophy experts in the field through conference calls, e-mail communications, a Delphi survey, and 2 in-person meetings to achieve consensus on 5 care areas: diagnostic/new interventions, pulmonary, gastrointestinal/nutrition, orthopedics/rehabilitation, and palliative care. Consensus was achieved on several topics related to common medical problems in spinal muscular atrophy, diagnostic strategies, recommendations for assessment and monitoring, and therapeutic interventions in each care area. A consensus statement was drafted to address the 5 care areas according to 3 functional levels of the patients: nonsitter, sitter, and walker. The committee also identified several medical practices lacking consensus and warranting further investigation. It is the authors' intention that this document be used as a guideline, not as a practice standard for their care. A practice standard for spinal muscular atrophy is urgently needed to help with the multidisciplinary care of these patients.

摘要

脊髓性肌萎缩症是一种需要多学科医疗护理的神经退行性疾病。在脊髓性肌萎缩症分子发病机制的理解方面取得的最新进展以及医疗技术的进步,并未在脊髓性肌萎缩症患者护理方面有类似的发展与之匹配。医疗实践的差异,再加上家庭资源和价值观的不同,导致了临床结果的差异,这很可能会影响临床试验中治疗效果的有效评估。脊髓性肌萎缩症国际护理标准委员会于2005年成立,目标是为这些患者的临床护理制定实践指南。12名核心委员会成员通过电话会议、电子邮件通信、德尔菲调查以及2次面对面会议,与该领域60多名脊髓性肌萎缩症专家合作,就5个护理领域达成共识:诊断/新干预措施、肺部、胃肠道/营养、骨科/康复以及姑息治疗。就与脊髓性肌萎缩症常见医疗问题、诊断策略、评估和监测建议以及每个护理领域的治疗干预措施相关的几个主题达成了共识。根据患者的3种功能水平:非坐立者、坐立者和行走者,起草了一份共识声明以涵盖这5个护理领域。委员会还确定了一些缺乏共识且有待进一步研究的医疗实践。作者的意图是将本文件用作指南,而非他们护理的实践标准。迫切需要脊髓性肌萎缩症的实践标准来帮助对这些患者进行多学科护理。

相似文献

1
Consensus statement for standard of care in spinal muscular atrophy.脊髓性肌萎缩症护理标准共识声明。
J Child Neurol. 2007 Aug;22(8):1027-49. doi: 10.1177/0883073807305788.
2
[Respiratory care for children with spinal muscular atrophy].[脊髓性肌萎缩症患儿的呼吸护理]
Zhonghua Er Ke Za Zhi. 2019 Oct 2;57(10):810-812. doi: 10.3760/cma.j.issn.0578-1310.2019.10.018.
3
Modern management of spinal muscular atrophy.脊髓性肌萎缩症的现代管理
J Child Neurol. 2007 Aug;22(8):974-8. doi: 10.1177/0883073807305670.
4
Spinal muscular atrophy with respiratory distress type 1 (SMARD1).1型伴有呼吸窘迫的脊髓性肌萎缩症(SMARD1)
J Child Neurol. 2008 Feb;23(2):199-204. doi: 10.1177/0883073807310989.
5
Diagnosis and clinical management of spinal muscular atrophy.脊髓性肌萎缩症的诊断与临床管理
Phys Med Rehabil Clin N Am. 2008 Aug;19(3):661-80, xii. doi: 10.1016/j.pmr.2008.02.004.
6
Respiratory management of the infant with type 1 spinal muscular atrophy.1型脊髓性肌萎缩症婴儿的呼吸管理
Arch Dis Child. 2005 Jul;90(7):709-11. doi: 10.1136/adc.2004.065961.
7
Complications after cardiovascular surgery in a case of undiagnosed spinal-bulbar muscular atrophy (Kennedy disease).心血管手术后一例未确诊的脊髓延髓肌萎缩症(肯尼迪病)的并发症。
Am J Crit Care. 2012 Mar;21(2):139-8. doi: 10.4037/ajcc2012453.
8
Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.伴有膈肌麻痹的远端型婴儿脊髓性肌萎缩症:婴儿脊髓性肌萎缩症的一种变异型
Am J Med Genet. 1989 Jul;33(3):328-35. doi: 10.1002/ajmg.1320330309.
9
[Spinal muscular atrophy in the ENT area].
Acta Otorrinolaringol Esp. 2007 Oct;58(8):378-80.
10
Diaphragmatic spinal muscular atrophy with bulbar weakness.伴有延髓肌无力的膈神经型脊髓性肌萎缩症
Eur J Paediatr Neurol. 2000;4(2):69-72. doi: 10.1053/ejpn.1999.0265.

引用本文的文献

1
The Effect of Aerobic Exercise Training on Patients with Type III Spinal Muscular Atrophy.有氧运动训练对III型脊髓性肌萎缩症患者的影响。
J Clin Med. 2025 Aug 28;14(17):6087. doi: 10.3390/jcm14176087.
2
Coexisting Rheumatoid Arthritis and Spinal Muscular Atrophy: A Case Report.类风湿关节炎与脊髓性肌萎缩症并存:一例报告
Cureus. 2025 Aug 11;17(8):e89779. doi: 10.7759/cureus.89779. eCollection 2025 Aug.
3
Single Nucleotide Variants in a Cohort of Individuals With Spinal Muscular Atrophy.脊髓性肌萎缩症患者队列中的单核苷酸变异
Neurol Genet. 2025 Aug 27;11(5):e200286. doi: 10.1212/NXG.0000000000200286. eCollection 2025 Oct.
4
Advancing personalized spinal muscular atrophy care: matching the right biomarker to the right patient at the right time.推进个性化脊髓性肌萎缩症护理:在正确的时间为正确的患者匹配正确的生物标志物。
J Neurol. 2025 Sep 2;272(9):605. doi: 10.1007/s00415-025-13314-7.
5
Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.脊髓性肌萎缩症治疗药物的上市后安全性:基于欧洲药物警戒数据库中自发药物不良反应的分析
J Clin Med. 2025 May 3;14(9):3173. doi: 10.3390/jcm14093173.
6
Rehabilitation improves the effectiveness of nusinersen in children with type 2 spinal muscular atrophy: pNF-H and muscle MRI as potential biomarkers.康复治疗可提高2型脊髓性肌萎缩症患儿使用诺西那生钠的疗效:磷酸化神经丝蛋白重链和肌肉磁共振成像作为潜在生物标志物
Front Neurol. 2025 Apr 11;16:1549587. doi: 10.3389/fneur.2025.1549587. eCollection 2025.
7
Regulatory insights on gene therapies, adeno-associated virus-based gene therapies, cell/tissue-based products, and medical care/practice in cell and gene therapies: Report from the 7th Asia partnership conference - April 25, 2024.基因疗法、腺相关病毒基因疗法、细胞/组织产品以及细胞和基因疗法中的医疗护理/实践的监管见解:第七届亚洲伙伴关系会议报告 - 2024年4月25日
Regen Ther. 2025 Apr 14;29:404-418. doi: 10.1016/j.reth.2025.02.007. eCollection 2025 Jun.
8
Scoliosis in spinal muscular atrophy in the era of disease-modifying therapy: a scoping review.疾病修饰治疗时代脊髓性肌萎缩症中的脊柱侧弯:一项范围综述
Neurol Sci. 2025 Apr 2. doi: 10.1007/s10072-025-08155-1.
9
Nutritional therapy in palliative care units: A bibliometric analysis.姑息治疗病房中的营养治疗:一项文献计量分析。
Medicine (Baltimore). 2025 Mar 7;104(10):e41772. doi: 10.1097/MD.0000000000041772.
10
"…They were just treating her Symptom by Symptom": maternal experiences of having a child with spinal muscular atrophy in Ghana.“……他们只是逐个症状地治疗她”:加纳一位患有脊髓性肌萎缩症孩子的母亲的经历
BMC Palliat Care. 2025 Feb 1;24(1):17. doi: 10.1186/s12904-025-01651-3.